isotretinoin

(redirected from Absorica)
Also found in: Medical.

i·so·tre·ti·noin

 (ī′sō-trĕt′n-oin′)
n.
A synthetic isomer of retinoic acid that inhibits sebaceous gland secretion and is used in the treatment of severe nodular acne. It can cause birth defects if taken during pregnancy.

[iso- + tretinoin, retinoic acid (t(rans)- + retino(ic acid) + -in).]

isotretinoin

(ˌaɪsəʊtrəˈtɪnəʊɪn)
n
(Pharmacology) a drug related to vitamin A, used to treat severe acne that has failed to respond to other treatment
Translations

isotretinoin

n isotretinoína
Mentioned in ?
References in periodicals archive ?
Sun Pharma's top selling drugs are Absorica, Gleevec and Doxil, while for Dr.
listed drugmaker Actavis over a version of skin care drug Absorica.
Ranbaxy maintained its strong market share in Absorica , isotretenoin NDA in the USA.
M2 EQUITYBITES-November 27, 2012-Ranbaxy Laboratories starts sales and promotion launch of Absorica Capsules(C)2012 M2 COMMUNICATIONS http://www.
M2 PHARMA-November 27, 2012-Ranbaxy Laboratories starts sales and promotion launch of Absorica Capsules(C)2012 M2 COMMUNICATIONS
RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Absorica (Isotretinoin) Capsules, a product that is licensed from Cipher Pharmaceuticals Inc.
The agreement extends the relationship with Cipher, under which Ranbaxy is marketing and distributing Cipher s isotretinoin product in the US under, Absorica.
PK) announced on Sunday that the US Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
Absorica is Cipher's novel, patented brand formulation of the acne medication isotretinoin, designed for the treatment of severe recalcitrant nodular acne.
Food and Drug Administration (FDA) has approved Absorica, a novel, patented brand formulation of the acne medication isotretinoin, developed by Cipher, for the treatment of severe recalcitrant nodular acne.